Filing Flows › Albemarle (ALB) › R&D spending
Albemarle (ALB) R&D spending by quarter
Albemarle's R&D spending was $8.2M in Q3 2026 (third quarter 2026), +123% from Q2 2026. Over the last 6 quarters it ranged from $3.7M (Q2 2026) to $12.7M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $8.2M | +123% | -36% |
| Q2 2026 | $3.7M | -60% | -71% |
| Q1 2026 | $9.2M | -25% | — |
| Q4 2025 | $12.2M | -4% | — |
| Q3 2025 | $12.7M | +2% | — |
| Q2 2025 | $12.4M | — | — |
Q3 2026 at a glance
Albemarle, Q3 2026: revenue $1.6B (+19% year over year), operating margin 9.5%, net earnings $297M, operating cash flow $406M. The chart follows the revenue to costs, profit and cash.
Questions
What is Albemarle's R&D spending?
Albemarle's R&D spending was $8.2M in Q3 2026 (third quarter 2026), +123% from Q2 2026.
How has Albemarle's R&D spending changed?
Over the last 6 quarters it ranged from $3.7M (Q2 2026) to $12.7M (Q3 2025).